EICHOR
● Recruiting
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
Condition: Atrial Fibrillation · Sponsor: VA Office of Research and Development
About this study
* The trial will compare two anticoagulants ("blood thinners") that are currently used in the VA and are considered standard care to prevent strokes in patients with atrial fibrillation. The two most commonly-used anticoagulants will be compared: apixaban (Eliquis) and rivaroxaban (Xarelto). They are considered by many doctors to have similar benefits and risks, but no one knows for sure. * The trial only enrolls patients with a diagnosis of atrial fibrillation ("A Fib") or atrial flutter. Most participants will be age 65 or older, and should already be taking apixaban or rivaroxaban. * The investigators will measure, in about 10,000 VA patients nationally, whether the rates of stroke, major bleeding, or death differ between these two drugs. * The trial will last about 7 years, but after the first prescription, all information will be collected from electronic medical records.
This description comes directly from the study's public registry record.
Talk to the study team
Mustabeen Ashfaq, MS · (857) 364-6026 · mustabeen.ashfaq@va.gov
Paul A Monach, MD PhD · (857) 364-5552 · Paul.Monach@va.gov
Always discuss trial participation with your own doctor first.
Locations (5)
| Miami VA Healthcare System, Miami, FL | Miami, Florida, United States | Recruiting |
| Boston VA CSP Coordinating Center | Boston, Massachusetts, United States | Recruiting |
| VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA | Boston, Massachusetts, United States | Not Yet Recruiting |
| Minneapolis VA Call Center | Minneapolis, Minnesota, United States | Recruiting |
| VA Portland Health Care System, Portland, OR | Portland, Oregon, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.